Bagnasco D - Search Results

1

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights.

Menzella F, Ruggiero P, Ghidoni G, Fontana M, Bagnasco D, Livrieri F, Scelfo C, Facciolongo N. Menzella F, et al. Among authors: bagnasco d. J Asthma Allergy. 2020 Sep 9;13:301-313. doi: 10.2147/JAA.S258594. eCollection 2020. J Asthma Allergy. 2020. PMID: 32982318 Free PMC article. Review.

2

A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.

Bagnasco D, Ferrando M, Varricchi G, Passalacqua G, Canonica GW. Bagnasco D, et al. Int Arch Allergy Immunol. 2016;170(2):122-31. doi: 10.1159/000447692. Epub 2016 Aug 3. Int Arch Allergy Immunol. 2016. PMID: 27637004 Free article. Review.

3

Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.

Passalacqua G, Canonica GW, Bagnasco D. Passalacqua G, et al. Among authors: bagnasco d. Curr Allergy Asthma Rep. 2016 Nov;16(12):88. doi: 10.1007/s11882-016-0666-x. Curr Allergy Asthma Rep. 2016. PMID: 27957697 Review.

4

Current insights in allergen immunotherapy.

Passalacqua G, Bagnasco D, Ferrando M, Heffler E, Puggioni F, Canonica GW. Passalacqua G, et al. Among authors: bagnasco d. Ann Allergy Asthma Immunol. 2018 Feb;120(2):152-154. doi: 10.1016/j.anai.2017.11.001. Ann Allergy Asthma Immunol. 2018. PMID: 29413339 Review.

5

Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life.

Lombardi C, Bagnasco D, Caruso C, D'Amato M, Menzella F, Milanese M, Senna G, Canonica GW, Passalacqua G. Lombardi C, et al. Among authors: bagnasco d, d amato m. Pulm Pharmacol Ther. 2019 Feb;54:87-89. doi: 10.1016/j.pupt.2018.12.003. Epub 2018 Dec 29. Pulm Pharmacol Ther. 2019. PMID: 30597278

6

Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?

Menzella F, Biava M, Bagnasco D, Galeone C, Simonazzi A, Ruggiero P, Facciolongo N. Menzella F, et al. Among authors: bagnasco d. Drugs Context. 2019 Apr 15;8:212580. doi: 10.7573/dic.212580. eCollection 2019. Drugs Context. 2019. PMID: 31024635 Free PMC article. Review.

7

Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?

Menzella F, Latorre M, Ruggiero P, Bagnasco D, Heffler E. Menzella F, et al. Among authors: bagnasco d. Expert Opin Biol Ther. 2019 Jul;19(7):601-606. doi: 10.1080/14712598.2019.1613367. Epub 2019 May 27. Expert Opin Biol Ther. 2019. PMID: 31033373 Review.

8

Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation.

Bagnasco D, Menzella F, Caminati M, Caruso C, Guida G, Bonavia M, Riccio A, Milanese M, Manfredi A, Senna G, Passalacqua G. Bagnasco D, et al. Allergy. 2019 Dec;74(12):2539-2541. doi: 10.1111/all.13937. Epub 2019 Jul 1. Allergy. 2019. PMID: 31166605 No abstract available.

9

Severe asthma, biologicals, and auto-injection: Yes, no, may be!

Lombardi C, Passalacqua G, Bagnasco D. Lombardi C, et al. Among authors: bagnasco d. Allergy. 2020 Feb;75(2):444-445. doi: 10.1111/all.13988. Epub 2019 Aug 14. Allergy. 2020. PMID: 31318070 No abstract available.

10

A case of chronic eosinophilic pneumonia in a patient treated with dupilumab.

Menzella F, Montanari G, Patricelli G, Cavazza A, Galeone C, Ruggiero P, Bagnasco D, Facciolongo N. Menzella F, et al. Among authors: bagnasco d. Ther Clin Risk Manag. 2019 Jul 10;15:869-875. doi: 10.2147/TCRM.S207402. eCollection 2019. Ther Clin Risk Manag. 2019. PMID: 31371974 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page